SuperCAP study is a project aimed at designing and implementing an online program for improvement of cognitive, emotional, and functional status in post-COVID condition.
SuperCAP study will include 2 stages. Stage 1 will involve the composition of a focus group previous to the effectiveness study development. The work with this focus group will have several aims, among them, mainly, to participate in the design of the intervention program, and to provide feedback on the study follow-up. Stage 2 will include the effectiveness study. This stage will comprise the initiation of the intervention program, study follow-up, and dissemination of the results in the end of the project. Two study groups will participate: the Intervention Group and the Control Group. The Intervention Group will be comprised by people with post-COVID condition who will follow the intervention program proposed. The Control Group will be comprised by people with post-COVID condition who will not follow the program. Both groups will fulfill the same study participation criteria. The intervention will consist of the follow-up of a distance program via mobile/tablet. This program will integrate different games and exercises always with the objective of stimulating the cognitive functioning and the emotional status.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
60
Distance program including tasks and exercises to improve cognitive, emotional, and functional status. The intervention will be applied via cell phone and will have a duration of 3 months (12 weeks). Tasks and exercises will be performed 5 days per week. Contents of the program will include daily exercises, daily games, daily videos, and weekly videos. They will address cognitive functions, daily habits, and lifestyle factors in general. Compliance will be monitored to control the adherence to the intervention. The program has been designed specifically for people with post-COVID syndrome.
Germans Trias I Pujol Hospital
Badalona, Barcelona, Spain
Change in Self-reported Cognitive Functioning
Understanding and Communicating Scale (D1) from WHODAS 2.0 questionnaire. Scores from 0 to 20. Lower scores indicate better functioning, higher scores worse functioning.
Time frame: From Baseline to Week 12
Change in Performance-based Cognitive Functioning
NPZ12, global neuropsychological measure. Scores from -5 to +5. Lower scores indicate worse functioning, higher scores better functioning.
Time frame: From Baseline to Week 12
Change in Depression Symptoms
PHQ-9 questionnaire. Scores from 0 to 27. Lower scores indicate fewer symptoms, higher scores more symptoms.
Time frame: From Baseline to Week 12
Change in Anxiety Symptoms
GAD-7 questionnaire. Scores from 0 to 21. Lower scores indicate fewer symptoms, higher scores more symptoms.
Time frame: From Baseline to Week 12
Change in Daily Activities Functioning
IADL scale. Scores from 0 to 20. Lower scores indicate better functioning, higher scores worse functioning.
Time frame: From Baseline to Week 12
Change in Physical Activity
IPAQ questionnaire. Scores from 0 to undetermined (total days, hours, minutes reported). Lower scores indicate worse activity, higher scores better activity.
Time frame: From Baseline to Week 12
Change in Quality of Life
EuroQoL-5D scale. Scores from 0 to 100. Lower scores indicate worse quality of life, higher scores better quality of life.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: From Baseline to Week 12